BRPI0909797A2 - Composição oftálmica - Google Patents
Composição oftálmicaInfo
- Publication number
- BRPI0909797A2 BRPI0909797A2 BRPI0909797A BRPI0909797A BRPI0909797A2 BR PI0909797 A2 BRPI0909797 A2 BR PI0909797A2 BR PI0909797 A BRPI0909797 A BR PI0909797A BR PI0909797 A BRPI0909797 A BR PI0909797A BR PI0909797 A2 BRPI0909797 A2 BR PI0909797A2
- Authority
- BR
- Brazil
- Prior art keywords
- ophthalmic composition
- cps
- composition
- blocker
- polyvinylpyrrolidone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
COMPOSIÇÃO OFTÁLMICA. A presente invenção refere-se a uma composição oftálmica compreendendo uma quantidade terapeuticamente eficaz de um beta-bloqueador e um veículo polimérico que consiste essencialmente em um derivado de celulose solúvel em água e polivinilpirrolidona; onde a composição é uma solução aquosa límpida com uma viscosidade de 20 cps a 60 cps.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN477MU2008 | 2008-03-07 | ||
PCT/IN2009/000162 WO2009110009A2 (en) | 2008-03-07 | 2009-03-09 | Opthalmic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0909797A2 true BRPI0909797A2 (pt) | 2017-08-22 |
Family
ID=41056432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0909797A BRPI0909797A2 (pt) | 2008-03-07 | 2009-03-09 | Composição oftálmica |
Country Status (9)
Country | Link |
---|---|
US (1) | US20110003816A1 (pt) |
EP (1) | EP2249871A4 (pt) |
JP (1) | JP2011513393A (pt) |
KR (1) | KR20100133980A (pt) |
CN (1) | CN101977630B (pt) |
BR (1) | BRPI0909797A2 (pt) |
CA (1) | CA2717825A1 (pt) |
MX (1) | MX2010009857A (pt) |
WO (1) | WO2009110009A2 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014515383A (ja) * | 2011-05-27 | 2014-06-30 | レイショファーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | PGF2α類似体を含む眼科用製剤 |
JP6260230B2 (ja) | 2013-11-28 | 2018-01-17 | ライオン株式会社 | 眼科用組成物 |
EP2979689A1 (en) * | 2014-07-29 | 2016-02-03 | Sygene Technologies | Composition for an eye drop and delivery system therefor |
CN106619573B (zh) * | 2016-12-27 | 2019-09-20 | 广州中大南沙科技创新产业园有限公司 | 马来酸噻吗洛尔立方液晶纳米粒滴眼液及其制备方法 |
EP3760207A4 (en) * | 2018-02-28 | 2023-10-04 | Santen Pharmaceutical Co., Ltd. | OPHTHALMIC COMPOSITION WITH DIQUAFOSOL AND CATIONIC POLYMER |
TW202320815A (zh) * | 2021-09-30 | 2023-06-01 | 日商樂敦製藥股份有限公司 | 眼科組成物 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4188373A (en) * | 1976-02-26 | 1980-02-12 | Cooper Laboratories, Inc. | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes |
US4136173A (en) * | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
US4136177A (en) * | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Xanthan gum therapeutic compositions |
US4470965A (en) * | 1982-10-27 | 1984-09-11 | Usv Pharmaceutical Corporation | Celiprolol for the treatment of glaucoma |
US4474752A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
US4474751A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
FR2588189B1 (fr) * | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
DE69212850T2 (de) * | 1991-01-15 | 1997-03-06 | Alcon Lab Inc | Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen |
JP2719049B2 (ja) * | 1991-01-28 | 1998-02-25 | 日本碍子株式会社 | ランタンクロマイト膜の製造方法及び固体電解質型燃料電池用インターコネクターの製造方法 |
SE512871C2 (sv) * | 1992-08-20 | 2000-05-29 | Santen Oy | Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension |
US5895645A (en) * | 1995-01-31 | 1999-04-20 | Bausch & Lomb Incorporated | Opthalmic solution for artificial tears |
US6335335B2 (en) * | 1997-11-05 | 2002-01-01 | Senju Pharmaceutical Co., Ltd. | Prolonged-action eye drop |
US6174524B1 (en) * | 1999-03-26 | 2001-01-16 | Alcon Laboratories, Inc. | Gelling ophthalmic compositions containing xanthan gum |
US6962691B1 (en) * | 1999-05-20 | 2005-11-08 | U & I Pharmaceuticals Ltd. | Topical spray compositions |
CN1245966C (zh) * | 1999-11-30 | 2006-03-22 | 爱尔康公司 | β-肾上腺素受体拮抗剂用于制备治疗外层视网膜疾病的药物的用途 |
WO2001047532A1 (fr) * | 1999-12-27 | 2001-07-05 | Santen Pharmaceutical Co., Ltd. | Système permettant de stabiliser la couche de fluide lacrymal |
EP1627637A1 (en) * | 2003-05-23 | 2006-02-22 | Santen Pharmaceutical Co., Ltd. | Ophthalmic solution containing quinolone antimicrobial compound |
US7063862B2 (en) * | 2003-06-03 | 2006-06-20 | Biokey, Inc. | Pharmaceutical composition and method for treating |
US7947295B2 (en) * | 2003-06-13 | 2011-05-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
KR101147046B1 (ko) * | 2003-06-13 | 2012-05-22 | 알콘, 인코퍼레이티드 | 시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물 |
TWI336257B (en) * | 2003-06-13 | 2011-01-21 | Alcon Inc | Ophthalmic compositions containing a synergistic combination of three polymers |
US6960300B2 (en) * | 2003-09-08 | 2005-11-01 | Sami Labs Limited | Process for preparing water soluble diterpenes and their applications |
WO2007002669A1 (en) * | 2005-06-28 | 2007-01-04 | Bausch & Lomb Incorporated | In-eye method of cleaning and/or disinfecting silicone hydrogel contact lenses |
-
2009
- 2009-03-09 EP EP09716930A patent/EP2249871A4/en not_active Withdrawn
- 2009-03-09 US US12/921,330 patent/US20110003816A1/en not_active Abandoned
- 2009-03-09 BR BRPI0909797A patent/BRPI0909797A2/pt not_active IP Right Cessation
- 2009-03-09 CA CA2717825A patent/CA2717825A1/en not_active Abandoned
- 2009-03-09 CN CN2009801095970A patent/CN101977630B/zh not_active Expired - Fee Related
- 2009-03-09 WO PCT/IN2009/000162 patent/WO2009110009A2/en active Application Filing
- 2009-03-09 MX MX2010009857A patent/MX2010009857A/es active IP Right Grant
- 2009-03-09 JP JP2010549260A patent/JP2011513393A/ja active Pending
- 2009-03-09 KR KR1020107020628A patent/KR20100133980A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2011513393A (ja) | 2011-04-28 |
CN101977630A (zh) | 2011-02-16 |
EP2249871A4 (en) | 2011-03-16 |
WO2009110009A3 (en) | 2009-12-23 |
US20110003816A1 (en) | 2011-01-06 |
KR20100133980A (ko) | 2010-12-22 |
CA2717825A1 (en) | 2009-09-11 |
CN101977630B (zh) | 2012-11-21 |
MX2010009857A (es) | 2010-12-07 |
WO2009110009A2 (en) | 2009-09-11 |
EP2249871A2 (en) | 2010-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0909797A2 (pt) | Composição oftálmica | |
BR112012007085B8 (pt) | processos para a preparação de derivados de benzil-benzeno substituídos com glicopiranosila | |
CR20150097A (es) | Composición inmunogénica | |
BR112015015408A2 (pt) | composição de revestimento, e, artigo revestido | |
BRPI1012368A2 (pt) | uso de celulose microfibrilada, composição viscosa e artigo | |
AR067815A1 (es) | Composicion de recubrimiento electrodepositable que contiene una guanidina ciclica | |
BR112012013504A2 (pt) | sistema marcador de evento ingerível integrado com produto farmacêutico | |
BR112015022861A8 (pt) | inibidores de bromodomínio | |
CR20110016A (es) | Compuestos quimicos 251 | |
BRPI0712631B8 (pt) | compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações | |
BR112012021577A2 (pt) | composição de branqueamento dos dentes | |
CR20140392A (es) | Dihidropirazolonas sustituidas | |
BRPI0910057A2 (pt) | composições cosméticas decorativas | |
PL2084235T3 (pl) | Zastosowanie kompozycji jako powłoki przeciw morskim biozanieczyszczeniom i uwalniającej morskie zanieczyszczenia | |
RS51646B (en) | TRICYCLIC UNITS AND THEIR USE AS MODULATORS OF GLUCOCORTICOID RECEPTORS | |
BRPI0703892A (pt) | revestimento aquoso à base de uma mistura de aglutinantes como revestimento de base | |
BRPI0508997A (pt) | microcamada com siloxanas | |
ATE531769T1 (de) | Verwendung von estern als koaleszenzmittel | |
BRPI0909630B8 (pt) | composição em suspensão aquosa particularmente adequada para injeção dentro do olho | |
MX2010002734A (es) | Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva. | |
BRPI0519958A2 (pt) | branqueamento de dente | |
MX2010001300A (es) | Uso de hesperidina o un derivado de la misma para prevencion y/o tratamiento de pieles flacidas. | |
HN2008001521A (es) | Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica | |
MX2010005053A (es) | Composicion de apresto para fibras de vidrio, fibras de vidrio aprestadas y productos reforzados que comprenden las mismas. | |
JO3676B1 (ar) | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |